FIELD: medicine.
SUBSTANCE: invention refers to medicine, gynaecology, birth control techniques used as and when necessary, and emergency contraception. Ulipristal acetate or its metabolite is administered orally in a female no more than 72 hours to 120 hours after a sexual encounter in a dose of 20 to 30 mg. Another dose can be administered again at least twice a month. The preparation can be administered either in the form of an immediate-release dosage form, in the form of a tablet.
EFFECT: method provides the high efficacy of emergency contraception even in low doses and late administration of the preparation - up to 120 hours after the sexual encounter as compared to a reference preparation of levonorgestrel.
7 cl
Title | Year | Author | Number |
---|---|---|---|
THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
METHOD FOR REDUCING RISK TO ACQUIRE MAMMARY GLAND CARCINOMA | 1992 |
|
RU2067001C1 |
TABLETS OF ULIPRISTAL ACETATE | 2009 |
|
RU2492853C2 |
ESTROGEN (PROGESTIN)-ANITOPROGESTIN METHOD OF PERORAL CONTRACEPTION AND MENSTRUATION CONTROL, PHARMACEUTICAL COMPOSITION, AND ASSEMBLY OF DRUGS | 1993 |
|
RU2127112C1 |
SCHEME OF ESTROGEN REPLENISHMENT | 2003 |
|
RU2340345C2 |
METHOD FOR PREVENTION OF OXIDATIVE STRESS ACCOMPANYING ADMINISTRATION OF RELEASING-HORMONE CONTRACEPTIVE SYSTEM | 2014 |
|
RU2563178C1 |
APPLICATION OF ANTIPROGESTAGENS IN COMBINED THERAPY | 2000 |
|
RU2234321C2 |
COMPOSITIONS AND A METHOD OF CONCEPTION PREVENTION | 1988 |
|
RU2114621C1 |
USE OF COMPETITIVE PROGESTERONE ANTAGONISTS FOR CONTRACEPTION, NEW COMPOUNDS OF ORDER OF COMPETITIVE PROGESTERONE ANTAGONISTS | 1993 |
|
RU2137476C1 |
METHODS FOR USING PROGESTOGEN AS GLUCOCORTICOID SENSITISER | 2011 |
|
RU2575824C2 |
Authors
Dates
2015-02-27—Published
2010-04-13—Filed